CCN2 and hepatocellular carcinoma: Both Id-1 and CCN2 levels were also obviously increased in HCC patients who were resistant to transcatheter arterial chemoembolization (TACE) compared with those TACE-susceptible patients (Fig. 1d; Supplementary Fig. 2).